Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,020 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Palbociclib in combination with either aromatase inhibitors or fulvestrant for patients with advanced HR+/HER2- breast cancer in Germany - Final results of the phase 2 multicohort INGE-B trial.
Welslau M, Potthoff K, Zaiss M, Müller L, Brucker C, Salat C, Untch M, Meiler J, Lüftner D, Welt A, Dörfel S, Hagen V, Stein A, Liersch R, Kuhn T, Siebenbach HU, Bing G, Vannier C, Marschner N, Gratzke K. Welslau M, et al. Among authors: stein a. Oncol Res Treat. 2024 Nov 15:1-20. doi: 10.1159/000542459. Online ahead of print. Oncol Res Treat. 2024. PMID: 39551040
Uncontrolled Illegal Mining and Garimpo in the Brazilian Amazon.
Cortinhas Ferreira Neto L, Diniz CG, Maretto RV, Persello C, Silva Pinheiro ML, Castro MC, Sadeck LWR, Filho AF, Cansado J, Souza AAA, Feitosa JP, Santos DC, Adami M, Souza-Filho PWM, Stein A, Biehl A, Klautau A. Cortinhas Ferreira Neto L, et al. Among authors: stein a. Nat Commun. 2024 Nov 13;15(1):9847. doi: 10.1038/s41467-024-54220-2. Nat Commun. 2024. PMID: 39537611 Free PMC article.
Inflammatory stress determines the need for chemotherapy in patients with HER2-positive esophagogastric adenocarcinoma receiving targeted and immunotherapy.
Tintelnot J, Paschold L, Goekkurt E, Schultheiss C, Matschl U, Santos Cruz M, Bauer M, Wickenhauser C, Thuss-Patience P, Lorenzen S, Ettrich TJ, Riera-Knorrenschild J, Jacobasch L, Kretzschmar A, Kubicka S, Al-Batran SE, Reinacher-Schick A, Pink D, Bokemeyer C, Sinn M, Lindig U, Hinke A, Hegewisch-Becker S, Stein A, Binder M. Tintelnot J, et al. Among authors: stein a. Cancer Immunol Res. 2024 Nov 11. doi: 10.1158/2326-6066.CIR-24-0561. Online ahead of print. Cancer Immunol Res. 2024. PMID: 39527097
Longitudinal effects of SARS-CoV-2 breakthrough infection on imprinting of neutralizing antibody responses.
Einhauser S, Asam C, Weps M, Senninger A, Peterhoff D, Bauernfeind S, Asbach B, Carnell GW, Heeney JL, Wytopil M, Fuchs A, Messmann H, Prelog M, Liese J, Jeske SD, Protzer U, Hoelscher M, Geldmacher C, Überla K, Steininger P, Wagner R; CoVaKo Study group. Einhauser S, et al. EBioMedicine. 2024 Nov 9;110:105438. doi: 10.1016/j.ebiom.2024.105438. Online ahead of print. EBioMedicine. 2024. PMID: 39522353 Free article.
3,020 results